Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.

about

Current Biochemical Monitoring and Risk Management of Immunosuppressive Therapy after Transplantation Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea

P2860

Q33801096-FE4450CA-106F-4BDE-B16A-3FC39AF1169A Q57213802-E89A3AD2-1381-4017-A2B6-F3C3ACE15611

P2860

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.

Item

http://www.wikidata.org/entity/Q42418219

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Open-Label, Randomized Study o ...... in Renal Allograft Recipients.

@en

Open-Label, Randomized Study o ...... in Renal Allograft Recipients.

@nl

type

Item

label

Open-Label, Randomized Study o ...... in Renal Allograft Recipients.

@en

Open-Label, Randomized Study o ...... in Renal Allograft Recipients.

@nl

prefLabel

Open-Label, Randomized Study o ...... in Renal Allograft Recipients.

@en

Open-Label, Randomized Study o ...... in Renal Allograft Recipients.

@nl

P1476

Open-Label, Randomized Study o ...... in Renal Allograft Recipients

@en

P2093

Alison Flynn

http://www.w3.org/2001/XMLSchema#string

Brad A Marder

http://www.w3.org/2001/XMLSchema#string

Carolyn M Hahn

http://www.w3.org/2001/XMLSchema#string

Graeme R Russ

http://www.w3.org/2001/XMLSchema#string

Helio Tedesco-Silva

http://www.w3.org/2001/XMLSchema#string

Huihua Li

http://www.w3.org/2001/XMLSchema#string

Michael A Tortorici

http://www.w3.org/2001/XMLSchema#string

Seth L Schulman

http://www.w3.org/2001/XMLSchema#string

V Ram Peddi

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus.

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

Impact and management of posttransplant diabetes mellitus.

New onset of diabetes after transplantation - an overview of epidemiology, mechanism of development and diagnosis.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Calcineurin inhibitor nephrotoxicity.

Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients

Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.

Safety of immunosuppressive drugs used as maintenance therapy in kidney transplantation: a systematic review and meta-analysis.

Conversion to mTOR-inhibitor-based immunosuppression: which patients and when?

P304

e69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TXD.0000000000000579

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Isabel Sanchez Fuctuoso

Fritz Diekmann

P577

2016-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27500260

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

4946511

http://www.w3.org/2001/XMLSchema#string

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.

about

P2860

P2860

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932